Sally Bridget Lawlor, Chief Financial Officer at Quoin Pharmaceuticals, bought QNRX on Aug 31, 2026

Data as of Oct 16

▲ BUY$50K10,244 shares at $4.88Sally Bridget Lawlor Chief Financial OfficerQNRX Quoin Pharmaceuticals, Ltd.

Watch QNRX

Traded: Aug 31, 2026
Disclosed: Sep 1, 2026
Filed: 1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

QNRXSimilar stocks (XLV — its sector index fund), rebased to QNRX's price on the disclosure day

QNRX since disclosure

−40.1%

Similar stocks (XLV) since disclosure

+2.9%

XLV — its sector index fund

Change in closing price from Sep 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

⚪ CFO buys $25K+ of own stock — fired on this trade
Not enough evidence · In past tests: 3.6 percentage points better than similar stocks over 3 months · 2,178 tries
⚪ CFO buys $25K+ of own liquid stock — fired on this trade
Not enough evidence · In past tests: 2.0 percentage points better than similar stocks over 3 months · 1,426 tries

What this rule is doing with QNRX right now

See pricing →

Already a member? Sign in

See every trade on QNRX →